Socio demographic, type of HAART, baseline clinical and laboratory characteristics of study participants stratified by treatment groups.
- Getnet Yimer (338188)
- Marcus Gry (548890)
- Wondwossen Amogne (338194)
- Eyasu Makonnen (157087)
- Abiy Habtewold (338191)
- Zelalem Petros (548891)
- Getachew Aderaye (338201)
- Ina Schuppe-Koistinen (143754)
- Lars Lindquist (316252)
- Eleni Aklillu (316254)
Publication date
April 2014
DOIAbstract
<p>Arm1 = HIV patients treated with efavirenz based HAART only.</p><p>Arm2 = TB-HIV patients with baseline CD4<200 cells/μL, treated with efavirenz based HAART and rifampicin based anti-tuberculosis drugs.</p><p>Arm3 = TB-HIV patients with baseline CD4>200 cells/μL, treated with rifampicin based anti-tuberculosis drugs only,</p><p>Arm4 = TB patients treated with rifampicin based anti-tuberculosis drugs only.</p
Add to ORKG